Official title and information are available only for Plus and Premium subscribers.
Patent Granted Recombinant alphavirus-based vectors have also been used to improve DNA vaccination efficiency.[2] The gene encoding the antigen of interest is inserted into the alphavirus replicon, replacing structural genes but leaving non-structural replicase genes intact. The Sindbis virus and Semliki Forest virus have been used to build recombinant alphavirus replicons.